Your session is about to expire
← Back to Search
Live Attenuated Influenza Vaccine for Flu
Study Summary
This trial will help researchers develop a model for influenza infection, by administering the live attenuated influenza vaccine to healthy volunteers and measuring the virus and immune responses in their nasal passages.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2012 Phase 3 trial • 6104 Patients • NCT01346592Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have smoked cigarettes in the last 6 months.I have a heart condition other than just high blood pressure.I have asthma.I have been diagnosed with congestive heart failure.I have had a respiratory infection in the last month.I have a long-term condition affecting my lungs, liver, kidneys, nervous system, blood, or metabolism.You had a bad reaction to the flu shot before.I am between 18 and 49 years old.I have not received the flu vaccine for 2019-2020.I have had Guillain-Barre syndrome in the past.I am able to understand and sign the consent form.I have not received the flu vaccine for 2019-2020.I am between 18 and 49 years old.I have diabetes.I have a condition or take medication that weakens my immune system.You are allergic to eggs.You have been in close contact with someone who has a weak immune system.You have ongoing sinus problems or nasal allergies that need regular treatment.I am able to understand and sign the consent form.
- Group 1: open label
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the age requirement for this study eighteen years or older?
"This clinical trial requires that participants are between 18 and 49 years old. For individuals younger than 18, there are 47 studies available; for seniors aged 65 or more, 81 trials can be found."
Who meets the eligibility criteria for this experiment?
"This research endeavor is currently accepting 20 individuals between 18 and 49 years old who have not yet been vaccinated for the 2019-2020 influenza season. The necessary qualifications are that applicants must fall within this age range, as well as meet any other prerequisites outlined in the study's protocols."
Are there openings available for participation in this experiment?
"This trial has expired, having been initially posted on September 1st 2020 and last updated July 14th 2022. Fortunately, there are 124 studies still actively recruiting patients with influenza plus 8 trials for this particular treatment that require participants."
How many participants will be accepted into this experiment?
"This clinical trial has since closed its recruitment phase. It was initially posted on September 1st 2020 and last updated July 14th 2022. For those seeking alternative studies, there are presently 124 trials for influenza research involving human subjects as well as 8 prospective medical trials with open enrolment criteria."
Are there any comparable research efforts that have utilized this therapy?
"At present, 8 trials for this medication are running with one of them in its third stage. Stanford University is the hub of these studies but there are an additional 7 research centres also participating."
Has this therapeutic intervention been accepted by the FDA?
"Data from the Phase 4 trial indicates that this treatment carries a high degree of safety and it was given a score of 3."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger